These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 5722887)

  • 1. Intramuscular perphenazine for the treatment of disturbed behavior.
    Ritter RM; Jaquith WL; Nail HR; Head JJ
    J Miss State Med Assoc; 1968 Nov; 9(11):532-3. PubMed ID: 5722887
    [No Abstract]   [Full Text] [Related]  

  • 2. [Perphenazine enantate in long-term therapy of psychoses].
    Gunby B
    Nord Psykiatr Tidsskr; 1968; 22(4):358-60. PubMed ID: 5710606
    [No Abstract]   [Full Text] [Related]  

  • 3. Perphenazine concentrations in human whole blood. A pilot study during anti-psychotic therapy using different administration forms.
    Hansen CE; Larsen NE
    Psychopharmacologia; 1974 Jun; 37(1):31-6. PubMed ID: 4415024
    [No Abstract]   [Full Text] [Related]  

  • 4. Mesoridazine in the care of disturbed mentally retarded patients.
    Lacny J
    Can Psychiatr Assoc J; 1973 Oct; 18(5):389-91. PubMed ID: 4746141
    [No Abstract]   [Full Text] [Related]  

  • 5. The prevention of disturbed behavior in psychiatric hospitals.
    Moore KB
    Curr Psychiatr Ther; 1980; 19():143-50. PubMed ID: 7460599
    [No Abstract]   [Full Text] [Related]  

  • 6. [Perphenazine enanthate in the treatment of chronic schizophrenia].
    Kampman R; Leppäluoto V
    Duodecim; 1970; 86(20):1167-70. PubMed ID: 5477736
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical experiences with perphenazine enanthate].
    Rafter B
    Nord Psykiatr Tidsskr; 1971; 25(4):371-4. PubMed ID: 5154124
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of the combination of fluoxetine and perphenazine in the treatment of psychotic depression.
    Rothschild AJ; Samson JA; Bessette MP; Carter-Campbell JT
    J Clin Psychiatry; 1993 Sep; 54(9):338-42. PubMed ID: 8104930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amitriptyline-perphenazine and doxepin in depressed outpatients: a controlled double-blind study.
    Rickels K; Csanalosi I; Werblowsky J; Weise CC; Weinstock R; Brown AS; Winokur A; Von Poelnitz M
    J Clin Psychiatry; 1982 Oct; 43(10):419-22. PubMed ID: 6749826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of perphenazine syrup in the severely disturbed mentally retarded child.
    Kaplitz SE
    IMJ Ill Med J; 1966 Dec; 130(6):785-7. PubMed ID: 4382839
    [No Abstract]   [Full Text] [Related]  

  • 11. [Perphenazine in ambulatory psychiatric services. Observations on 212 cases].
    Tienari P
    Duodecim; 1966; 82(4):161-4. PubMed ID: 5943363
    [No Abstract]   [Full Text] [Related]  

  • 12. [Paranoid psychosis in acute intermittent porphyria treated with perphenazine].
    Stibolt O; Thunell S
    Ugeskr Laeger; 1998 Nov; 160(45):6529-31. PubMed ID: 9816964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of agitation in institutionalized aged females.
    Salzberger GJ
    Dis Nerv Syst; 1966 Jul; 27(7):481-2. PubMed ID: 5942786
    [No Abstract]   [Full Text] [Related]  

  • 14. [Personality and the extrapyramidal side effects of perphenazine].
    Mäkelä S
    Nord Psykiatr Tidsskr; 1967; 21(2):136-44. PubMed ID: 5597915
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of perphenazine in psychiatric emergencies: the concept of chemical restraint.
    Fann WE; Linton PH
    Curr Ther Res Clin Exp; 1972 Aug; 14(8):478-82. PubMed ID: 4629310
    [No Abstract]   [Full Text] [Related]  

  • 16. Interpreting the results of the CATIE study.
    Luchins DJ
    Psychiatr Serv; 2006 Jan; 57(1):139-40. PubMed ID: 16399979
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment with psychotropic drugs in various facilities for mentally handicapped patients].
    Meins W; Auwetter J; Krausz M; Turnier Y
    Nervenarzt; 1993 Jul; 64(7):451-5. PubMed ID: 8103571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Open trial study of a combined antidepressant (amitryptiline, perphenazine, diazepam) versus fluoxetine or imipramine in ambulatory depressed patients.
    Diaz A; Fouilloux C; Ortiz S
    Proc West Pharmacol Soc; 2002; 45():154-5. PubMed ID: 12434564
    [No Abstract]   [Full Text] [Related]  

  • 19. Platelet monoamine oxidase activity in neuroleptic-naive schizophrenic patients: lack of influence of chronic perphenazine treatment.
    Spivak B; Kosower N; Zipser Y; Shreiber-Schul N; Apter A; Tyano S; Weizman A
    Clin Neuropharmacol; 1994 Feb; 17(1):83-8. PubMed ID: 8149362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiemetic effect of perphenazine versus prochlorperazine intravenously before cisplatin therapy.
    Smaglia RA; Parkinson DR; Taylor CD
    Clin Pharm; 1984; 3(1):68-71. PubMed ID: 6365417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.